Novartis Asks SCOTUS to Deny Review of Gilenya Patent Decision

17th February 2021

Novartis Asks SCOTUS to Deny Review of Gilenya Patent Decision · More from Bloomberg Law.

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.

RECENT PATENT NEWS…

From Silicon Valley to Skincare: HI-TECH Beauty Labs Announces U.S. Patent for B3 Technology® - PR Newswire
Fed. Circ. Affirms Toss Of Hulu Digital Advertising Patent Suit - Law360
Microbiology Student Captured Trying To Flee to China After Allegedly Poisoning Colleague Over Coveted Technology Patents - The New York Sun
Patented: Citi’s AI-Generated Suspicious Activity Reports and 105 More Inventions Across North Texas - Dallas Innovates

UK BUSINESS NEWS…

Drop-off charges at UK airports to be reviewed after sharp increase
Netflix to shed 1,000 jobs in steepest cuts since 2022
'It's rough out here': Americans struggle with rising inflation
Toilet paper and secret recorders: What we know about the arrest of the Saudi OpenAI engineer

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION